Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.19.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balances at beginning at Dec. 31, 2017 $ 106,937 $ 106,757,920 $ (101,036,117) $ 5,828,740
Balances at beginning (in shares) at Dec. 31, 2017 10,693,851      
Issuances of common stock:        
Share-based compensation $ 93 247,372   247,465
Share-based compensation (in shares) 9,298      
Under contractual arrangements $ 250 77,250   77,500
Under contractual arrangements (in shares) 25,000      
Warrant exercises $ 978 235,620   236,598
Warrant exercises (in shares) 97,747      
Net loss for the period     (1,640,917) (1,640,917)
Balances at ending at Mar. 31, 2018 $ 108,258 107,318,162 (102,677,034) 4,749,386
Balances at ending (in shares) at Mar. 31, 2018 10,825,896      
Balances at beginning at Dec. 31, 2017 $ 106,937 106,757,920 (101,036,117) 5,828,740
Balances at beginning (in shares) at Dec. 31, 2017 10,693,851      
Issuances of common stock:        
Net loss for the period       (3,517,453)
Balances at ending at Jun. 30, 2018 $ 110,064 108,002,861 (104,553,570) 3,559,355
Balances at ending (in shares) at Jun. 30, 2018 11,006,439      
Balances at beginning at Mar. 31, 2018 $ 108,258 107,318,162 (102,677,034) 4,749,386
Balances at beginning (in shares) at Mar. 31, 2018 10,825,896      
Issuances of common stock:        
Share-based compensation $ 320 359,339   359,659
Share-based compensation (in shares) 31,977      
Warrant exercises $ 1,486 325,360   326,846
Warrant exercises (in shares) 148,566      
Net loss for the period     (1,876,536) (1,876,536)
Balances at ending at Jun. 30, 2018 $ 110,064 108,002,861 (104,553,570) 3,559,355
Balances at ending (in shares) at Jun. 30, 2018 11,006,439      
Balances at beginning at Dec. 31, 2018 $ 110,183 108,600,405 (107,199,586) 1,511,002
Balances at beginning (in shares) at Dec. 31, 2018 11,018,364      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cumulative adjustment for adoption of new accounting standard     (244) (244)
Issuances of common stock:        
Share-based compensation $ 285 152,301   152,586
Share-based compensation (in shares) 28,462      
Warrant exercises $ 204 (204)    
Warrant exercises (in shares) 20,381      
Net loss for the period     (1,220,725) (1,220,725)
Balances at ending at Mar. 31, 2019 $ 110,672 108,752,502 (108,420,555) 442,619
Balances at ending (in shares) at Mar. 31, 2019 11,067,207      
Balances at beginning at Dec. 31, 2018 $ 110,183 108,600,405 (107,199,586) 1,511,002
Balances at beginning (in shares) at Dec. 31, 2018 11,018,364      
Issuances of common stock:        
Net loss for the period       (2,771,120)
Balances at ending at Jun. 30, 2019 $ 136,863 116,741,229 (109,970,950) 6,907,142
Balances at ending (in shares) at Jun. 30, 2019 13,686,320      
Balances at beginning at Mar. 31, 2019 $ 110,672 108,752,502 (108,420,555) 442,619
Balances at beginning (in shares) at Mar. 31, 2019 11,067,207      
Issuances of common stock:        
Share-based compensation $ 32 203,962   203,994
Share-based compensation (in shares) 3,251      
Warrant exercises $ 1,894 381,182   383,076
Warrant exercises (in shares) 189,407      
May 2019 private placement, net of offering costs of $94,162 $ 24,265 7,403,583   7,427,848
May 2019 private placement, net of offering costs of $94,162 (in shares) 2,426,455      
Net loss for the period     (1,550,395) (1,550,395)
Balances at ending at Jun. 30, 2019 $ 136,863 $ 116,741,229 $ (109,970,950) $ 6,907,142
Balances at ending (in shares) at Jun. 30, 2019 13,686,320